Mariana Lazo

Mariana Lazo

Auto-generated profile, based on publicly available information

Mariana Lazo

Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD; Department of Epidemiology and the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
MLMariana Lazo
Mariana Lazo
IZIrfan Zeb
Irfan Zeb
KNKhurram Nasir
Khurram Nasir
RTRussell P. Tracy
Russell P. Tracy
MBMatthew J. Budoff
Matthew J. Budoff
DVDhananjay Vaidya
Dhananjay Vaidya

1 April 2015 in Journal of Hepatology
Verified
Journal Article
Closed access
MLMariana Lazo
Mariana Lazo
JRJonathan Rubin
Jonathan Rubin
JCJeanne M. Clark
Jeanne M. Clark
JCJosef Coresh
Josef Coresh
ASAndrea L.C. Schneider
Andrea L.C. Schneider
ESElizabeth Selvin
Elizabeth Selvin

1 November 2015 in American Heart Journal
Verified
Journal Article
Closed access
MLMariana Lazo
Mariana Lazo
MHMarc Halushka
Marc Halushka
LSLu Shen
Lu Shen
NMNisa Maruthur
Nisa Maruthur
CRCasey M. Rebholz
Casey M. Rebholz
ESElizabeth Selvin
Elizabeth Selvin

14 October 2015 in Current Diabetes Reports
Verified
Journal Article
Closed access
PDF file
MLMariana Lazo
Mariana Lazo
UBUsama Bilal
Usama Bilal
RPRafael Perez-Escamilla
Rafael Perez-Escamilla

1 December 2017 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
MLMariana Lazo
Mariana Lazo
CNChizoba Nwankwo
Chizoba Nwankwo
NDNatalie R. Daya
Natalie R. Daya
DTDavid L. Thomas
David L. Thomas
SMShruti H. Mehta
Shruti H. Mehta
ESElizabeth Selvin
Elizabeth Selvin

11 December 2018 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
YHYun Soo Hong
Yun Soo Hong
SRSeungho Ryu
Seungho Ryu
YCYoosoo Chang
Yoosoo Chang
MCMiguel Caínzos-Achirica
Miguel Caínzos-Achirica
MKMin-Jung Kwon
Min-Jung Kwon
EGEliseo Guallar
Eliseo Guallar
The effect of chronic hepatitis B virus (HBV) infection on the risk of chronic kidney disease (CKD) is controversial. We examined the prospective association between hepatitis B surface antigen (HBsAg) serology status and incident CKD in a large cohort of men and women. Cohort study of 299,913 adults free of CKD at baseline who underwent health screening exams between January 2002 and December 2016 in South Korea. Incident CKD was defined as the development of an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 and/or proteinuria. Over 1,673,701 person-years of follow-up, we observed 13,924 incident cases of CKD (3225 cases of eGFR < 60 ml/min/1.73m2 and 11,072 cases of proteinuria). In fully adjusted models comparing positive to negative HBsAg participants, the hazard ratio (HR, 95% confidence interval) for incident CKD was 1.11 (1.03–1.21; P = 0.01). The corresponding HR for incident proteinuria and for eGFR < 60 ml/min/1.73m2 were 1.23 (1.12–1.35; P < 0.001) and 0.89 (0.73–1.07; P = 0.21), respectively. The associations were similar across categories of liver enzyme levels at baseline. In this large cohort, HBsAg positive serology was associated with higher risk of incident CKD, and we provide novel evidence that this association was due to a higher incidence of proteinuria in HBsAg positive participants. Our study adds to the growing body of evidence suggesting that chronic HBV infection may be a contributor to the increasing incidence of CKD.